Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Novartis AG acquires CoStim Pharmaceuticals, Inc. for undisclosed amount


Monday, 17 Feb 2014 06:31am EST 

MPM Capital and Atlas Venture:Says portfolio company CoStim Pharmaceuticals, Inc. has been acquired by Novartis for an undisclosed amount.CoStim, founded in 2012 by MPM Managing Director Luke Evnin together with MPM Managing Director-Operations Robert Millman.Says MPM provided the initial capital to found CoStim, and later co-led the formal Series A investment in early 2013 with Atlas Venture. 

Company Quote

100.4
0.84 +0.84%
27 Mar 2015